Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 2/2001

01-02-2001

Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer

Authors: Hyun Soo Kim, Dong Ki Lee, Kwang Hyun Kim, Yon Soo Jeong, Jae Woo Kim, Jeong In Seo, Soon Ku Baik, Sang Ok Kwon, Mee Yon Cho

Published in: Journal of Gastroenterology | Issue 2/2001

Login to get access
Metadata
Title
Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer
Authors
Hyun Soo Kim
Dong Ki Lee
Kwang Hyun Kim
Yon Soo Jeong
Jae Woo Kim
Jeong In Seo
Soon Ku Baik
Sang Ok Kwon
Mee Yon Cho
Publication date
01-02-2001
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 2/2001
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s005350170137

Other articles of this Issue 2/2001

Journal of Gastroenterology 2/2001 Go to the issue

Case report

Primary intestinal lymphangiectasia successfully treated with octreotide

OriginalPaper

Melatonin's gastroprotective and antistress roles involve both central and peripheral effects

Editorial

Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B

Editorial

What are the objectives of treatment for intestinal lymphangiectasia?

OriginalPaper

Growth inhibition and apoptosis of gastric cancer cell lines by Anemarrhena asphodeloides Bunge

OriginalPaper

Mutation at codon 130 in hepatitis B virus (HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits